Discover 161 paid clinical trials in Fresno, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 161
Featured
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor
for
Upper Limb Essential Tremor
Location: Fresno CA, Fullerton CA, Carlsbad CA, Spokane WA,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07673107
Phase 2, Recruiting
Featured
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
for
Chronic Migraine
Location: Fresno CA, San Jose CA, Walnut Creek CA, Long Beach CA,
Sponsor: AbbVie
Sex: All
Age: 12 - 17
Code: NCT06810505
Phase 3, Recruiting
Featured
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
for
Migraine
Location: Fresno CA, Modesto CA, San Jose CA, Walnut Creek CA,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05125302
Phase 3, Recruiting
Featured
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Location: Fresno CA, Sacramento CA, Homewood AL, Tucson AZ,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18 - 70+
Code: NCT06419374
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Featured
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: Clovis CA, Palo Alto CA, Roseville CA, San Francisco CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06793215
Phase 3, Recruiting
Featured
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
for
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Location: Clovis CA, San Francisco CA, Glendale CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06806033
Phase 2, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine
for
Preventive Treatment of Migraine
Location: Fresno CA, Canoga Park CA, Los Angeles CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07729462
Phase 3, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: Fresno CA, Sacramento CA, Thousand Oaks CA,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT06628908
Phase 3, Recruiting
Active & Responsive
Study of EVO756 in Adults With Migraine
for
Migraine
Location: Fresno CA, Walnut Creek CA, Los Angeles CA,
Sponsor: Evommune, Inc.
Sex: All
Age: 18 - 64
Code: NCT07616128
Phase 2, Recruiting
Active & Responsive
ACP-204 in Adults With Alzheimer's Disease Psychosis
for
Alzheimer's Disease Psychosis
Location: Fresno CA, Pasadena CA, Costa Mesa CA, Scottsdale AZ,
Sponsor: ACADIA Pharmaceuticals Inc.
Sex: All
Age: 55 - 70+
Code: NCT06159673
Phase 2, Phase 3, Recruiting
Active & Responsive
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)
for
Venous Leg Ulcer (VLU)
Location: Fresno CA, San Francisco CA, Los Angeles CA, Vista CA,
Sponsor: MediWound Ltd
Sex: All
Age: 18+
Code: NCT06568627
Phase 3, Recruiting
Active & Responsive
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Location: Fresno CA, San Francisco CA, Lancaster CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07165028
Phase 3, Recruiting
Active & Responsive
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
for
Generalized Myasthenia Gravis
Location: Fresno CA, Sylmar CA, Orange CA, Rancho Mirage CA,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT04202341
Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer